---
title: What to Know About Nasal Adenocarcinoma
description: Nasal adenocarcinomas are invasive nasal cancers in dogs. Explore treatment options, including precision medicine, and prognosis.
image: https://blog.fidocure.com/hubfs/Blog_NasalAdenocarcinoma.png
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
# What to Know About Nasal Adenocarcinoma
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma)
Nasal adenocarcinomas are relatively uncommon but represent nearly two-thirds of nasal tumors in dogs, which are locally invasive and have a higher risk of metastasis in later stages. Radiation therapy is the primary treatment to slow tumor growth, with patients living around one year on average. Newer approaches like metronomic chemotherapy and precision medicines targeting mutations show promise in delaying progression and metastasis.
Medium-to-large breed dogs may be more prone to developing nasal tumors. Additionally, long-nosed (dolichocephalic) breeds or dogs living in urban environments could be at higher risk, possibly due to increased exposure to environmental carcinogens.
**Treatment Options**
Surgical removal of nasal tumors is not often recommended due to the high morbidity rate and lack of significant increase in life expectancy. Therefore, radiation therapy is usually the primary treatment of choice. It has been shown to slow down tumor growth and, in some cases, shrink the mass. Radiation therapy is also used to help alleviate clinical signs such as nasal discharge, bleeding, and increased respiratory effort.
Traditional injectable chemotherapy is not typically used for nasal tumors, as this cancer is more of a local concern. However, newer therapies may be effective against nasal carcinomas. Oral metronomic therapy, which involves low-dose chemotherapy combined with a non-steroidal anti-inflammatory medication given daily, can help reduce blood vessel growth into the tumor and thus delay tumor growth and metastasis.
Furthermore, precision medicine has also been studied to treat [nasal adenocarcinomas](https://www.nature.com/articles/s41698-023-00346-3#citeas). Nasal adenocarcinomas have been reported to carry alterations in genes including ATM, BRCA1, BRCA2 TP53, and VEGF that can be targeted with precision therapies. FidoCure enables access to these precision medications and may require routine check-ups to ensure tolerability and assess tumor response.
**Prognosis**
The average survival time with radiation therapy alone is approximately one year, with some patients living longer than the average. As for traditional chemotherapy, small studies have reported life expectancy between 5-7 months. For targeted therapy, the long-term prognosis is still being studied, but shows promise in extending life expectancy. One [study](https://doi.org/10.1111/vco.12776) found that the targeted therapy Palladia had a median survival time (MST) of 298 days, while combining Palladia with radiation therapy extended the MST to 615 days, demonstrating significant potential for improving outcomes.
For the most accurate prognosis and treatment recommendations for your dog with nasal adenocarcinoma, consult your veterinarian or a veterinary oncologist. They can provide personalized guidance based on your dog's specific case, considering factors such as cancer stage, grade, tumor location, and concurrent health issues.
## Related Articles
[](https://blog.fidocure.com/fidocure-blog/precision-medicine-for-canine-mammary-gland-tumors)
### [Precision Medicine for Canine Mammary Gland Tumors](https://blog.fidocure.com/fidocure-blog/precision-medicine-for-canine-mammary-gland-tumors)
Mammary tumors are common in intact female dogs, especially middle-aged and older dogs of smaller breeds like Poodles, Chihuahuas, and Dachshunds, though some larger...
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Read More](https://blog.fidocure.com/fidocure-blog/precision-medicine-for-canine-mammary-gland-tumors)
[](https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/medical-brief-the-median-isnt-the-message/amp)
### [Medical Brief:The Median Isn’t the Message](https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/medical-brief-the-median-isnt-the-message/amp)
### Stephen J. Gould was one of the most influential authors of popular science. He was a paleontologist, evolutionary biologist and historian of science.
The “Median Isn’t...
[Dr. Gerry Post](https://blog.fidocure.com/fidocure-blog/author/dr-gerry-post)
[Read More](https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/medical-brief-the-median-isnt-the-message/amp)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "FidoCure",
"url" : "https://blog.fidocure.com/fidocure-blog/author/fidocure"
},
"dateModified" : "2024-09-04T13:00:02.514Z",
"datePublished" : "2024-09-04T13:00:00.000Z",
"headline" : "What to Know About Nasal Adenocarcinoma",
"image" : [ "https://blog.fidocure.com/hubfs/Blog_NasalAdenocarcinoma.png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/what-to-know-about-nasal-adenocarcinoma",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```